Matisse Capital’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,500
Closed -$391K 130
2018
Q2
$391K Buy
2,500
+1,000
+67% +$156K 0.31% 73
2018
Q1
$242K Buy
+1,500
New +$242K 0.15% 108